Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.

Cellular and molecular biology (Noisy-le-Grand, France)

Volumn 42, Issue 5, 1996, Pages 769-778

  Ledda, M F ^a   Adris, S ^a   Bravo, A I ^a   Bover, L ^a   Carbone, C ^a   Paleolog, E ^a   Mordoh, J ^a   Chernajovsky, Y ^a   Podhajcer, O L ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADENOCARCINOMA; ANIMAL; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER INVASION; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; COLON TUMOR; DISEASE MODEL; EXPERIMENTAL MELANOMA; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; ISOGRAFT; KINETICS; MOUSE; NUDE MOUSE; PATHOLOGY; RAT; T LYMPHOCYTE;

ADENOCARCINOMA; ANIMALS; B-LYMPHOCYTES; CELL DIVISION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENETIC ENGINEERING; INTERLEUKIN-6; KINETICS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RATS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; TRANSPLANTATION, ISOGENEIC; TUMOR CELLS, CULTURED;

EID: 0030179905     PISSN: 01455680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)